Stem cell program wins key court ruling, poised to issue grants
By San Francisco Chronicle,
San Francisco Chronicle
| 11. 30. 2005
California's embattled Proposition 71 stem cell program took a big step Tuesday toward overcoming lawsuits that have blocked its first grants from being issued.
Alameda County Superior Court Judge Bonnie Sabraw denied essentially every legal argument brought by the plaintiffs in litigation alleging that Prop. 71 violated the state Constitution because it would allow taxpayer-backed bond revenues to be distributed without direct legislative control.
The Prop. 71 program was created by state voters in November 2004 with authority to disperse $3 billion in grants during the next 10 years, mostly intended to advance controversial embryonic stem cell research. A state agency called the California Institute for Regenerative Medicine has been created and based in San Francisco.
Lawsuits challenging the institute's plans were filed by taxpayer groups and an anti-abortion bioethics organization, frustrating research advocates who say stem cells are key to creating a radical new kind of cell-based medicine that is potentially capable of curing such maladies as Parkinson's disease, diabetes and spinal cord injuries.
Now, the program's leadership hopes to move forward by January with a stopgap funding plan...
Related Articles
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
By Christina Jewett, The New York Times | 06.05.2025
Health Secretary Robert F. Kennedy Jr. recently declared that he wanted to expand access to experimental therapies but conceded that they could be risky or fraudulent.
In a podcast with Gary Brecka, who describes himself as a longevity expert...
By Mike Baker, The New York Times | 02.25.2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that...
